share_log

Legend Biotech | 6-K: Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA

Legend Biotech | 6-K: Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA

传奇生物 | 6-K:传奇生物将在ASCO和EHA上展示其在多发性骨髓瘤患者CAR-T细胞治疗领域的领导地位
美股SEC公告 ·  05/23 17:01
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息